Could a patient with a history of taking psychotropic medications, including fluoxetine (selective serotonin reuptake inhibitor), escitalopram (selective serotonin reuptake inhibitor), divalproex (valproate), buspirone (anxiolytic), and dextroamphetamine-amphetamine (central nervous system stimulant), who discontinued them 3 months ago, and now presents with tingling in both lower legs and feet, have multiple sclerosis (MS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Could This Patient Have Multiple Sclerosis?

Tingling in both lower legs and feet after discontinuing psychotropic medications 3 months ago is unlikely to be MS and should first prompt evaluation for medication-related peripheral neuropathy, particularly given the recent use of divalproex and amphetamines, which can cause peripheral nerve symptoms.

Primary Differential Diagnosis: Medication-Induced Neuropathy

The clinical presentation strongly suggests a peripheral neuropathy rather than MS:

  • Bilateral lower extremity tingling in a symmetric distribution is characteristic of peripheral neuropathy, not the typical asymmetric, multifocal CNS lesions seen in MS 1
  • Divalproex (valproate) and amphetamines are both associated with peripheral neuropathy and neurological symptoms 2
  • The 3-month timeline after medication discontinuation is consistent with medication-induced neuropathy, which can persist or emerge after drug cessation 3

Why MS Is Less Likely

MS diagnosis requires demonstrating inflammatory-demyelinating injury within the CNS that is disseminated in both time and space 1. Key features that argue against MS in this case:

  • Isolated sensory symptoms in a symmetric, distal, bilateral pattern (stocking distribution) is typical of peripheral neuropathy, not MS 3, 1
  • MS typically presents with discrete episodes of numbness, tingling, weakness, vision loss, gait impairment, incoordination, imbalance, or bladder dysfunction that are asymmetric and involve different CNS locations 1
  • No mention of other CNS symptoms such as optic neuritis, brainstem symptoms, bladder dysfunction, or motor weakness that would suggest multifocal CNS involvement 1

Clinical Evaluation Approach

Perform a thorough neurologic examination focusing on:

  • Sensory testing in a stocking-glove distribution pattern 3
  • Deep tendon reflexes (typically reduced or absent in peripheral neuropathy, preserved or hyperactive in MS) 1
  • Motor strength testing (primarily sensory in peripheral neuropathy; MS can have motor involvement) 3
  • Gait assessment and coordination testing 1

Consider laboratory evaluation if peripheral neuropathy is suspected:

  • Serum B12, folate, thyroid function, glucose/HbA1c 3
  • Electrolyte panel 3
  • EMG/nerve conduction studies can confirm peripheral neuropathy but are not routinely necessary if clinical diagnosis is clear 3

When to Consider MS Workup

Only pursue MS evaluation if the patient develops:

  • Additional CNS symptoms involving different anatomic locations (optic neuritis, brainstem symptoms, bladder dysfunction) 1
  • Asymmetric neurological deficits 1
  • Episodes separated in time with intervening stability or partial recovery 1
  • Upper motor neuron signs (hyperreflexia, spasticity, Babinski sign) 1

If MS remains a consideration, obtain brain and spinal cord MRI looking for periventricular and subcortical white matter lesions, oval-shaped lesions (Dawson's fingers), and gadolinium-enhancing lesions indicating active inflammation 1, 4

Critical Red Flags

Watch for rapid progression of symptoms, development of bulbar dysfunction, or muscle atrophy, which could indicate more serious neurodegenerative conditions and warrant urgent neurological consultation 4

Avoid premature MS diagnosis based solely on isolated sensory symptoms without objective MRI evidence of CNS demyelination and dissemination in time and space 1

Related Questions

What is the best psych medication for a patient with Multiple Sclerosis (MS)?
What is the best course of action for a patient with a history of Multiple Sclerosis (MS) presenting with increased confusion and weakness, who is on long-term Isoniazid (Isonicotinylhydrazide) 300 MG oral tablets for chronic tremors, with stable lab results including a normal Urinalysis (UA) and B12 level, and a pending neurology consult?
What is the best course of treatment for a 27-year-old patient with a 12-year history of increased urinary frequency, normal neurological exam except for flexor plantars and exaggerated reflexes, VEP (Visual Evoked Potential) suggestive of demyelination, and MRI (Magnetic Resonance Imaging) findings of T2W/FLAIR (Fluid-Attenuated Inversion Recovery) hyperintensities in the juxta cortical region and periventricular white matter, suspected to have Multiple Sclerosis (MS) with a low disability score?
What are the current diagnostic criteria for multiple sclerosis?
Does a patient with a history of Multiple Sclerosis (MS) presenting with left facial, arm, and leg changes in sensation and a questionable new upper C2 lesion on brain MRI require treatment prior to cervical spine MRI results?
Can a patient with a history of depression or bipolar disorder take Vibryd (vilazodone) with lithium?
What are the differential diagnoses and next steps for an elderly male with reduced appetite, unintentional weight loss, and a 3cm by 1cm mass-like structure in the common bile duct, with normal total bilirubin levels?
What is the duration that Zepbound (tirzepatide) stays in the system of an adult patient with type 2 diabetes or metabolic concerns?
What is the best cough medicine for a patient with coronary artery disease (CAD)?
What is the best approach to manage suicidal ideations in an elderly patient with a history of chronic conditions and potential cognitive decline?
Why does a patient's hypokalemia persist despite potassium supplementation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.